We speculate that cerebrovascular disease may be another possible modifiable risk factor for PSP, as such vascular factors may pose a risk to accentuating PSP 4-repeat tau damage by microvascular co-pathology (26). Here, MAPT is linked to supranuclear palsy, progressive, 1.